MAIA Biotechnology, Inc. (NYSE American: MAIA) ('MAIA”, the 'Company”), a clinical-stage biopharmaceutical company focused on ...

PSA is a validated FDA-recognized clinical endpoint in assessing prostate cancer treatment response; Telomir-1 lowered PSA ...

Beyond scientific innovation, experts say the development of clonal hybrid rice is capable of improving lives of millions of ...

The 2025 iC³® Life Science & Healthcare Innovation Summit, hosted by BioNTX, concluded on September 16-17 at the Hilton Anatole in Dallas, marking more than a decade of progress, partnership, and ...

As bispecifics, ADCs, protein degraders, and AI-designed mini-proteins move into the clinic, discovery teams face a new ...

For many Europeans, "Brussels" evokes images the overpaid political hack gaming the system. Weber has become their poster boy ...

"What's next for smart implants in health care?" details how advanced medical devices, embedded with sensors and data analytics capabilities, are moving beyond passive tissue replacement to become ...

The identification of the remains was based on a contemporary osteological analysis, but they were subsequently lost and only ...

Inc., a biotechnology company pioneering next-generation tissue therapeutics for organ replacement, today announced the completion of its ...

Several European biotechs, including Cellbox Labs, Evotec SE, Nanolive SA, and Salipro Biotech AB, have developed innovative ...

Shares of Regeneron Pharmaceuticals (NASDAQ: REGN), a biotech giant, have been southbound over the past two years as the ...

The analysis, conducted by Pentara Corporation in collaboration with scientists from ProMIS, provides important new evidence that plasma phosphorylated tau (pTau181 and pTau217) can serve as a ...